Pfizer?s Ibrance drug slows progression of breast cancer
 

Pfizer?s Ibrance drug slows progression of breast cancer
CHICAGO May 30 (Reuters) - A Phase III trial of Pfizer Inc's drug Ibrance showed that, in combination with hormone therapy, the drug more than doubled the duration of disease control for women with the most common type of breast cancer.http://i0.wp.com/reuters.us.feedspor...f?resize=1%2C1


http://da.feedsportal.com/r/22876787...14/rc/1/rc.img
http://da.feedsportal.com/r/22876787...14/rc/2/rc.img
http://da.feedsportal.com/r/22876787...14/rc/3/rc.img

http://da.feedsportal.com/r/22876787...e/sc/14/a2.img
http://adchoice.feedsportal.com/r/22.../sc/14/ach.imghttp://pi.feedsportal.com/r/22876787.../sc/14/a2t.imghttp://pi2.feedsportal.com/r/2287678...sc/14/a2t2.img http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...pM:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...pM:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/eSjUb25SiDU